Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
11:34 | Cordel Group - Further progress in the UK and internationally | 106 | Cordel's new customer win in the Middle East expands its global customer footprint, providing further validation of the company's product market fit and long-term revenue opportunity. Meanwhile, the... ► Artikel lesen | ||
09:34 | Dar Global - £200m Aston Martin branded residence unveiled | 126 | Dar Global's latest luxury branded residential project, its first with Aston Martin, fits well with its strategy and follows its other recent announcements including its initiative in the Maldives with... ► Artikel lesen | ||
Di | Card Factory - Look inside the card | 121 | Card Factory (CARD) is aiming to become the leading omnichannel retailer of greeting cards, gifts and celebration essentials in the UK as well as select international markets. In the UK, its extensive... ► Artikel lesen | ||
Di | Picton Property Income - Organic growth accelerating | 118 | Picton Property Income's 6% increase in the rate of quarterly DPS from Q423 demonstrates an increasing confidence in the outlook for organic income and earnings growth. The occupier market has remained... ► Artikel lesen | ||
Mo | IRLAB Therapeutics - Mesdopetam disease-modifying potential | 129 | Researchers in China studying IRLAB's lead asset, mesdopetam (IRL790) in a preclinical model for levodopa-induced dyskinesia in Parkinson's disease (PD-LIDs) have noted that the treatment not only improved... ► Artikel lesen | ||
Fr | Norcros - Robust performance, improving outlook | 142 | Norcros's FY24 results highlight its resilience in the face of tough markets, but we continue to believe that the outlook is improving in both of its core markets, the UK and South Africa. Despite the... ► Artikel lesen | ||
Fr | Custodian Property Income REIT - Organic earnings and dividend growth | 149 | Custodian Property Income REIT (CREI) has published results for the year ended 31 March 2024 (FY24). As previously indicated in the Q424 update, set against a challenging market environment, FY24 performance... ► Artikel lesen | ||
Fr | Oryzon Genomics - Encouraging interim update on FRIDA | 180 | Oryzon Genomics has reported positive interim data from the Phase Ib FRIDA study, evaluating iadademstat in combination with gilteritinib in advanced acute myeloid leukaemia (AML) patients. Results... ► Artikel lesen | ||
11.06. | S&U - Elevated regulatory impact | 132 | S&U's Q125 trading update disclosed increased pressure as the company steers cautiously through the changing regulatory landscape. The payment rate in the Advantage motor finance business fell to 87.7%... ► Artikel lesen | ||
11.06. | Northern Data Group - Building its European AI ecosystem | 336 | Northern Data has announced a number of initiatives that underline management's commitment to be at the forefront of AI and high-performance computing (HPC) innovation in Europe. The launch of an AI... ► Artikel lesen | ||
11.06. | Martin Currie Global Portfolio Trust - Manager 'sticking to his knitting'; positive outlook | 122 | Martin Currie Global Portfolio Trust (MNP) has been managed by Zehrid Osmani since October 2018. He runs a high-conviction, relatively concentrated portfolio of quality growth companies with pricing... ► Artikel lesen | ||
10.06. | SDCL Energy Efficiency Income Trust - Answering five key investor questions | 166 | In this note we examine five key questions investors have raised regarding SDCL Energy Efficiency Income Trust (SEEIT), prior to the release of its full-year results (for the year ended March 2024)... ► Artikel lesen | ||
06.06. | OSE Immunotherapeutics - Strong momentum in deal flow | 204 | OSE Immunotherapeutic's FY24 has started off with a series of major wins, significantly bolstering the company's clinical pipeline and liquidity. We believe the partnership with AbbVie (announced in... ► Artikel lesen | ||
05.06. | AUSTRIACARD - Outlook points to H2-weighted growth | 193 | AUSTRIACARD reported adjusted revenue growth of 1.4% for Q124, reflecting comparison to a particularly strong Q123. Better sales mix and good control over the cost base resulted in expansion of the... ► Artikel lesen | ||
05.06. | Altron - Transformation plan drives margin growth | 176 | Altron's FY24 results confirmed good progress with its strategic plan, with headline EPS from continuing operations up 36% y-o-y and well ahead of our forecast. The bulk of restructuring is now complete... ► Artikel lesen | ||
05.06. | Checkit - Potential bid for Crimson Tide | 200 | Checkit has announced a formal approach to the board of Crimson Tide, an AIM-listed provider of workflow management software, regarding a possible all-share offer for the company at a value of £12m.... ► Artikel lesen | ||
04.06. | Invesco Asia Trust - Patiently waiting for re-rating of Chinese equities | 224 | Invesco Asia Trust (IAT) posted a one-year NAV total return (TR) to end-May 2024 of 3.8%, below its benchmark return of 8.7%, as some of IAT's Chinese stock picks de-rated significantly over the period.... ► Artikel lesen | ||
04.06. | OPAP - Steady progress towards FY24 guidance | 337 | OPAP delivered good revenue growth in Q124 while profitability declined, mainly due to the upfront investment to support a major new product launch, which should boost revenue as the year progresses... ► Artikel lesen | ||
04.06. | Oryzon Genomics - ALICE data published in The Lancet Haematology | 155 | Oryzon Genomics has announced the publication of the final ALICE trial results in the recognised peer-reviewed journal The Lancet Haematology. The Phase IIa trial investigated iadademstat (Oryzon's... ► Artikel lesen | ||
03.06. | Melrose Industries - Crystallisation of the 2020 Employee Share Plan | 190 | The crystallisation of the employee plan highlights the value created through the GKN acquisition, benefiting from the strong performance from the restructuring programme and current positive trends... ► Artikel lesen | ||
03.06. | Renewi - UK Municipal exit offers an inflection point | 203 | The proposed sale of the UK Municipal business is a major step in exiting significant liabilities and risk, along with focusing Renewi as a European specialist in recycling, generating higher-value... ► Artikel lesen | ||
03.06. | IRLAB Therapeutics - Valuation uplift supported by IRL757 | 172 | IRLAB Therapeutics is swiftly progressing with the Phase I trial for IRL757, with the first participant recently dosed following regulatory approval earlier this month. IRL757 is being developed for... ► Artikel lesen | ||
31.05. | Braemar - Diversification underpins resilience | 204 | Braemar's FY24 results were in line with expectations with revenues flat, but operating profits down, having been hit by one-off costs and strong comparatives. The underlying operations continue to... ► Artikel lesen | ||
30.05. | Helios Underwriting - Healthy FY23 beat supports strong outlook | 191 | Helios Underwriting (Helios) delivered a strong EPS recovery in FY23 from a loss of 3.1p in FY22 to a profit of 21.6p, 50% ahead of our forecast of 14.7p, driven by super syndicate underwriting profit... ► Artikel lesen | ||
30.05. | Oryzon Genomics - EC taps Oryzon for healthcare initiative | 235 | The European Commission has selected Oryzon to support a new healthcare initiative furthering innovation in the region. As an associated partner of the recently announced Med4Cure initiative, Oryzon... ► Artikel lesen |